These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4843743)

  • 21. [Activity of the fibrin-stabilizing factor in acute leukemia].
    Tentsova IA
    Probl Gematol Pereliv Krovi; 1974; 19(5):33-6. PubMed ID: 4524610
    [No Abstract]   [Full Text] [Related]  

  • 22. [Dysproteinemic diseases and hemorrhagic tendency].
    Ueda N; Miyamura S
    Rinsho Byori; 1971 Aug; 19(8):537-43. PubMed ID: 4999543
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrinogen-fibrin degradation products and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 51(6):321-30. PubMed ID: 4212013
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic primary cryofibrinogenaemia in childhood. Report of one case and a review of the literature (author's transl)].
    Fernandez JM; Madrona DP; Gomez RB; Roldan AN; Illescas MC
    Sangre (Barc); 1975; 20(2):225-32. PubMed ID: 1145401
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of childhood polyarteritis nodosa associated with cryofibrinogenaemia presenting in adulthood with massive gastrointestinal bleeding.
    Meehan SE; Coghill SB; Cuschieri A
    Scott Med J; 1983 Jul; 28(3):302-5. PubMed ID: 6137058
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemorrhagic diathesis].
    Mesters RM; Stenzinger W
    Internist (Berl); 1995 Jan; 36(1):77-90. PubMed ID: 7883536
    [No Abstract]   [Full Text] [Related]  

  • 27. [Presence of a plasma antigen indispensable to the stabilization of fibrin in 2 cases on congenital factor XIII deficiency].
    Soria J; Soria C; Samama M; Josso F
    Thromb Diath Haemorrh; 1970 Dec; 24(3):356-60. PubMed ID: 5511868
    [No Abstract]   [Full Text] [Related]  

  • 28. [CONGENITAL BLOOD COAGULATION DISORDER ASSOCIATED WITH A DEFICIENCY OF FIBRIN-STABILIZING FACTOR (FSF)].
    MASURE R
    Hemostase; 1963; 3():119-22. PubMed ID: 14050809
    [No Abstract]   [Full Text] [Related]  

  • 29. Disseminated intravascular coagulation.
    Hollán SR; Mód A
    Haematologia (Budap); 1976; 10(3-4):319-30. PubMed ID: 1028666
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Clin Invest; 1962 Apr; 41(4):896-916. PubMed ID: 13893560
    [No Abstract]   [Full Text] [Related]  

  • 31. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemorrhagic diathesis caused by a deficiency of the fibrin-stabilizing factor (factor 13)].
    Lechler E; Köhler J
    Verh Dtsch Ges Inn Med; 1968; 74():144-7. PubMed ID: 5714300
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma].
    Lopaciuk S; Snigurowicz J; Rostkowska J; Pniejnia-Olszyński W; Powiertowska-Rezmer M
    Acta Haematol Pol; 1978; 9(3):157-64. PubMed ID: 102100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Congenital deficiency of fibrin stabilizing activity. Presence of a protein immunologically analogous to factor XIII].
    Aguercif M; Nigg OM; Lopez JM; Bouvier CA
    Nouv Rev Fr Hematol; 1971; 11(6):841-8. PubMed ID: 4261156
    [No Abstract]   [Full Text] [Related]  

  • 35. Cryoprecipitate shortens the bleeding time and reduces bleeding complications in patients with uremia.
    Jubelirer SJ; Janson PA; Weinstein MJ; Deykin D
    Trans Assoc Am Physicians; 1980; 93():182-91. PubMed ID: 6787774
    [No Abstract]   [Full Text] [Related]  

  • 36. [Factor XIII, its physiological significance (a review of the literature)].
    Baluda VP; Zhukova NA
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):34-40. PubMed ID: 4271843
    [No Abstract]   [Full Text] [Related]  

  • 37. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
    Anders O; Görss EW; Ernst B; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Congenital deficiency of fibrin stabilizing factor (factor XIII)].
    Barbui T; Di Luzio V
    G Clin Med; 1968 Jun; 49(6):646-61. PubMed ID: 4907419
    [No Abstract]   [Full Text] [Related]  

  • 39. [Coagulation disorders in tumors and hemoblastoses].
    Zurborn KH; Bernsmeier R; Schamerowski F; Stöhr A; Bruhn HD
    Onkologie; 1982 Aug; 5(4):186-90. PubMed ID: 6755331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ; Shulman NR; Carroll WR
    Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.